Testing a way to detect low muscle in women with certain cancers
Part of Brain & nervous system, Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at whether doctors can spot “low muscle” (sarcopenia) in everyday clinic care for people with ovarian or endometrial cancer who are planning to start chemotherapy. It may help your care team identify muscle loss early and potentially support better treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older
- Have ovarian cancer or endometrial cancer and plan to receive chemotherapy
- No other type of cancer diagnosed in the past 5 years (except certain skin/cervix cancers)
- You can provide informed consent to join the study
- Be covered by a Social Security health plan (in the study system)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how muscle loss (sarcopenia) might affect side effects from cancer treatments. If you are starting a new cancer treatment, a CT scan before treatment can help doctors predict your risk of side effects.
This study looks at how common muscle weakness (sarcopenia) and thinking or memory changes (often called “chemobrain”) are in people after cancer treatment. It may help teams understand what support could be most helpful after chemotherapy.
This trial looks at muscle loss (called sarcopenia) in people with colon cancer to test an intervention that may help strength or recovery. If you’re age 70 or older and meet the cancer and health requirements, you may be able to take part.
This trial tests whether a structured exercise program can help breast cancer survivors who have low muscle mass and strength (sarcopenia). If you've finished your main treatments and are now in recovery, this study may help improve your muscle health.
This trial looks at muscle loss (sarcopenia) in women who are pre-menopause or post-menopause, and whether hormone replacement therapy affects it. It aims to understand how muscle health changes over a woman's life.
This study tests whether a special exercise program can help women with breast or gynecological cancer who have lost muscle strength or mass (sarcopenia). It aims to improve your muscle health after finishing your main cancer treatments.
Hear when a new Ovarian Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.